Dragon America Cancer Consulting

In the US, cancer is the second most common cause of death. Unfortunately cancer can strike an unprepared person at any time, and many cancer patients when diagnosed are at a late stage for which limited FDA-approved treatment options are available.

At Dragon America Cancer Consulting, we specialize in helping cancer patients and their caregivers to navigate through dedicated cancer resources and address their specific concerns using live online training and personalized assistance. Most dedicated cancer resources are available to the public but each contains vast amount of information that can be overwhelming to someone new. Our cancer experts have decades of experience in cancer research and cancer drug development through working with scientific, industrial and regulatory channels including FDA. They are well versed with leading cancer resources and can offer the services to help new/existing cancer patients and their caregivers to gather latest information on standard of care and become self-sufficient to utilize those support resources, which has also proven to be very effective to alleviate psychological stress on the patients and caregivers.

Specifically for late-stage cancer patients, we can provide the latest details on promising cancer clinical trial (Phase I/II/III registered with FDA) results on those late-stage cancers. Many of these investigational drugs are using cutting-edge immunotherapy/targeted therapy/cell therapy and have enabled some stage 4 patients to achieve complete response and/or staying progression free for 24+ months, however, the results are generally not available to the public due to the investigational nature. In fact, due to FDA's lengthy regulatory process to approve an investigational drug, there could be a lag of 2-5 years between the time an investigational drug is shown to be promising in a clinical trial and the time the drug is finally approved. Our cancer experts gather these crucial information about promising early results through industrial channels and and can provide detailed updates and reports to empower late-stage cancer patients and their caregivers to have better informed discussions with their cancer care team and/or contact drug companies directly, as drug companies are usually open to allowing more patients enrolled in ongoing clinical trials or can even offer an investigational drug to patients on a compassionate basis.

Moreover, we generate our detailed clinical trial updates and reports every 3 months for all common cancer types, including lung cancer, colon cancer and breast cancer. These updates and reports are more general in nature as they cover a variety of different cancers, but they do focus on promising treatment options beyond current standard of care, and could offer valuable yet potentially life-changing options to a late-stage cancer patient who has exhausted treatment options with one's cancer care team.